🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical study is in subjects who are 18 years old or older with local...
Status
Completed
Location
Mayo Clinic - Arizona
Start Date
2015-04-21
Trial ID
NCT02301143
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as panitumumab, can block tumor grow...
Status
Completed
Location
Aurora Presbyterian Hospital
Start Date
2009-06
Trial ID
NCT00601627
Treatments Being Tested
This phase II randomized trial compares the efficacy and safety of Toripali...
Status
Recruiting
Location
Dongguan People's Hospital
Start Date
2026-03-12
Trial ID
NCT07362979
This randomized phase II trial studies how well high or standard intensity ...
Status
Terminated
Location
Kaiser Permanente Oakland-Broadway
Start Date
2013-08
Trial ID
NCT01921751
The NCCN guidelines recommend induction chemotherapy followed by concurrent...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-03-19
Trial ID
NCT06301165
Treatments Being Tested
Proton Beam Therapy (PBT) is an advanced radiotherapy technique. There are ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT06434493
This research study is for people who have pancreas cancer for which surger...
Status
Active Not Recruiting
Location
Froedtert Hospital
Start Date
2015-12-10
Trial ID
NCT01972919
Treatments Being Tested
This is an interventional, single arm, open-label, feasibility trial with g...
Status
Recruiting
Location
EBG MedAustron GmbH
Start Date
2020-09-14
Trial ID
NCT04894643
This study aims to explore the efficacy and safety of risk-adapted adjuvant...
Status
Recruiting
Location
Fudan Universtiy Shanghai Cancer Center
Start Date
2026-08
Trial ID
NCT07762976
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as cetuximab, can block tumor growth...
Status
Completed
Location
Hollings Cancer Center at Medical University of South Carolina
Start Date
2006-01
Trial ID
NCT00408564
Treatments Being Tested